Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE:Psyop

RE:Psyop

posted on Feb 15, 2006 06:14AM
Not a bad question. Noone has follwed up on my confirmation request, but I would guess that S&L have shares close to 9.98% of the 304mil outstanding =over 30mil. Plus Debentures of say 15mil. plus Warrants of 123+mil,which includes the recent 7mil incentive.joe
Share
New Message
Please login to post a reply